Physician profile
Barbara E Wolff
NPI 1023171576
$7,680.06
in general payments reported to CMS, 2019-2025
29 companies · $1,800 in 2025
The $1,800 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,172 · 2022: $1,285 · 2023: $1,280 · 2024: $2,143 · 2025: $1,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,034 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,034.26 |
| Education | $188.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,648.07 | 2021-2025 | |
| Janssen Biotech, INC. | $892.05 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $737.22 | 2021-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $721.58 | 2021-2025 | Ilumya, Blu-U, Odomzo |
| Ani Pharmaceuticals, INC. | $461.05 | 2024 | Purified Cortrophin Gel |
| Amgen INC. | $409.93 | 2022-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $388.85 | 2021-2025 | |
| Genzyme Corporation | $372.37 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $319.25 | 2022-2024 | Sotyktu |
| Organogenesis INC. | $265.56 | 2022-2025 | Affinity, Puraply Wound Matrix, Puraply |
| Leo Pharma INC. | $237.88 | 2024-2025 | Adbry, Anzupgo |
| Ucb, INC. | $185.47 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $168.23 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $159.26 | 2025 | |
| Lilly USA, LLC | $153.78 | 2021-2024 | Taltz |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $78.47 | 2024-2025 | Opzelura |
| Sanofi-Aventis U.S. LLC | $69.99 | 2021 | |
| Convatec INC. | $57.69 | 2024-2025 | |
| Galderma Laboratories, L.P. | $57.58 | 2021-2022 | |
| Biofrontera INC. | $55.38 | 2021-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.54 | 2022-2025 | Spevigo |
| Organon LLC | $41.49 | 2023-2025 | Hadlima, Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.05 | 2025 | Cabtreo, Jublia, Siliq |
| Almirall LLC | $34.33 | 2021-2022 | |
| Integra Lifesciences Corporation | $22.37 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ets Wound Care LLC | $19.60 | 2025 | Mirragen Advanced Wound Matrix |
| Jazz Pharmaceuticals INC. | $17.59 | 2021 | |
| Smith+Nephew, INC. | $14.61 | 2025 | Pico |
| Kerecis Limited | $1.82 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.